Stocktoria

Olema Pharmaceuticals, Inc. OLMA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-11-19

Olema Pharmaceuticals, Inc. statistics & valuation

Market cap$994.9M
P / B2.1×
Return on equity-33.9%
Return on capital-37.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-6.50% -25.00% -53.00% -38.10% -31.70% -33.90% 202020212022202320242025
Shares outstanding
39.3M 39.8M 40.3M 55.0M 74.3M 87.0M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-6.50% -24.00% -48.60% -34.90% -28.70% -30.50% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$3.42 -$1.80 -$2.62 -$2.14 -$2.20 -$1.87 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-30.5%-28.7%-34.9%-48.6%-24.0%-6.5%
Return on equity-33.9%-31.7%-38.1%-53.0%-25.0%-6.5%
Current ratio9.9510.5012.3312.6232.2374.62

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.